Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells

Gliomas are the most common and aggressive primary tumors in the central nervous system. The nucleoside adenosine is considered to be one major constituent within the tumor microenvironment. The adenosine level mainly depends on two enzymatic activities: 5′-nucleotidase (5′NT or CD73) that synthesiz...

Full description

Bibliographic Details
Main Authors: Alejandro Sánchez-Melgar, Sonia Muñoz-López, José Luis Albasanz, Mairena Martín
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2021.702817/full
_version_ 1818586456156798976
author Alejandro Sánchez-Melgar
Sonia Muñoz-López
José Luis Albasanz
Mairena Martín
author_facet Alejandro Sánchez-Melgar
Sonia Muñoz-López
José Luis Albasanz
Mairena Martín
author_sort Alejandro Sánchez-Melgar
collection DOAJ
description Gliomas are the most common and aggressive primary tumors in the central nervous system. The nucleoside adenosine is considered to be one major constituent within the tumor microenvironment. The adenosine level mainly depends on two enzymatic activities: 5′-nucleotidase (5′NT or CD73) that synthesizes adenosine from AMP, and adenosine deaminase (ADA) that converts adenosine into inosine. Adenosine activates specific G-protein coupled receptors named A1, A2A, A2B, and A3 receptors. Resveratrol, a natural polyphenol present in grapes, peanuts, and berries, shows several healthy effects, including protection against cardiovascular, endocrine, and neurodegenerative diseases and cancer. However, the molecular mechanisms of resveratrol actions are not well known. Recently, we demonstrated that resveratrol acts as an agonist for adenosine receptors in rat C6 glioma cells. The present work aimed to investigate the involvement of adenosine metabolism and adenosine receptors in the molecular mechanisms underlying the antitumoral action of resveratrol. Results presented herein show that resveratrol was able to decrease cell numbers and viability and to reduce CD73 and ADA activities, leading to the increase of extracellular adenosine levels. Some resveratrol effects were reduced by the blockade of A1 or A3 receptors by DPCPX or MRS1220, respectively. These results suggest that reduced CD73 activity located in the plasma membrane in addition to a fine-tuned modulatory role of adenosine receptors could be involved, at least in part, in the antiproliferative action of resveratrol in C6 glioma cells.
first_indexed 2024-12-16T08:53:15Z
format Article
id doaj.art-36daa0fa6c5f4def8c85d9280757c432
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-12-16T08:53:15Z
publishDate 2021-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-36daa0fa6c5f4def8c85d9280757c4322022-12-21T22:37:22ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2021-09-011510.3389/fnins.2021.702817702817Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma CellsAlejandro Sánchez-MelgarSonia Muñoz-LópezJosé Luis AlbasanzMairena MartínGliomas are the most common and aggressive primary tumors in the central nervous system. The nucleoside adenosine is considered to be one major constituent within the tumor microenvironment. The adenosine level mainly depends on two enzymatic activities: 5′-nucleotidase (5′NT or CD73) that synthesizes adenosine from AMP, and adenosine deaminase (ADA) that converts adenosine into inosine. Adenosine activates specific G-protein coupled receptors named A1, A2A, A2B, and A3 receptors. Resveratrol, a natural polyphenol present in grapes, peanuts, and berries, shows several healthy effects, including protection against cardiovascular, endocrine, and neurodegenerative diseases and cancer. However, the molecular mechanisms of resveratrol actions are not well known. Recently, we demonstrated that resveratrol acts as an agonist for adenosine receptors in rat C6 glioma cells. The present work aimed to investigate the involvement of adenosine metabolism and adenosine receptors in the molecular mechanisms underlying the antitumoral action of resveratrol. Results presented herein show that resveratrol was able to decrease cell numbers and viability and to reduce CD73 and ADA activities, leading to the increase of extracellular adenosine levels. Some resveratrol effects were reduced by the blockade of A1 or A3 receptors by DPCPX or MRS1220, respectively. These results suggest that reduced CD73 activity located in the plasma membrane in addition to a fine-tuned modulatory role of adenosine receptors could be involved, at least in part, in the antiproliferative action of resveratrol in C6 glioma cells.https://www.frontiersin.org/articles/10.3389/fnins.2021.702817/fullresveratrolgliomaCD73adenosine receptorbrain
spellingShingle Alejandro Sánchez-Melgar
Sonia Muñoz-López
José Luis Albasanz
Mairena Martín
Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells
Frontiers in Neuroscience
resveratrol
glioma
CD73
adenosine receptor
brain
title Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells
title_full Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells
title_fullStr Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells
title_full_unstemmed Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells
title_short Antitumoral Action of Resveratrol Through Adenosinergic Signaling in C6 Glioma Cells
title_sort antitumoral action of resveratrol through adenosinergic signaling in c6 glioma cells
topic resveratrol
glioma
CD73
adenosine receptor
brain
url https://www.frontiersin.org/articles/10.3389/fnins.2021.702817/full
work_keys_str_mv AT alejandrosanchezmelgar antitumoralactionofresveratrolthroughadenosinergicsignalinginc6gliomacells
AT soniamunozlopez antitumoralactionofresveratrolthroughadenosinergicsignalinginc6gliomacells
AT joseluisalbasanz antitumoralactionofresveratrolthroughadenosinergicsignalinginc6gliomacells
AT mairenamartin antitumoralactionofresveratrolthroughadenosinergicsignalinginc6gliomacells